US Patent Issued to Azura Ophthalmics on Oct. 27 for "Metered dose for Demodex and disorders related thereto" (Israeli, American, Australian Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,424, issued on Oct. 27, was assigned to Azura Ophthalmics Ltd. (Tel Aviv, Israel).

"Metered dose for Demodex and disorders related thereto" was invented by Omer Rafaeli (Udim, Israel), Charles Bosworth (Las Vegas), Marc Gleeson (Longueville, Australia), Yair Alster (Tel Aviv, Israel) and Hadas Rapaport (Zofar, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are pharmaceutical compositions and methods treating Demodex or a disorder thereof around the eye by application of a metered dose of a semi-solid product from a product tube."

The patent was filed on May 2, 2022, under Application No. 17/734,900.

*For further information,...